| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $1.5M | -95.2% |
| SG&A Expense | $8.1M | -43.9% |
| Operating Income | -$13.0M | +70.8% |
| Pre-tax Income | -$5.3M | +88.1% |
| Income Tax | $0 | — |
| Net Income | -$5.3M | +88.1% |
| EPS (Basic) | -$2.25 | -122.8% |
| EPS (Diluted) | -$2.25 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.6M | -43.4% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $8.0M | -45.9% |
| Total Assets | $13.4M | -26.0% |
| Current Liabilities | $2.1M | -72.6% |
| Stockholders' Equity | $11.3M | +8.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.2M | +47.7% |
| Investing Cash Flow | $10.4M | — |
| Financing Cash Flow | $5.0M | — |
| -122.8% |